These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 9833910)
41. Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Okolicsanyi L; Groppo M; Floreani A; Morselli-Labate AM; Rusticali AG; Battocchia A; Colombo M; Galatola G; Gasbarrini G; Podda M; Ricci G; Rosina F; Zuin M Dig Liver Dis; 2003 May; 35(5):325-31. PubMed ID: 12846404 [TBL] [Abstract][Full Text] [Related]
42. Primary sclerosing cholangitis and bile acids. Chazouillères O Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S21-5. PubMed ID: 23141889 [TBL] [Abstract][Full Text] [Related]
43. Primary sclerosing cholangitis. Stiehl A; Benz C; Sauer P Can J Gastroenterol; 2000 Apr; 14(4):311-5. PubMed ID: 10799084 [TBL] [Abstract][Full Text] [Related]
44. Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis. Lindström L; Hultcrantz R; Boberg KM; Friis-Liby I; Bergquist A Clin Gastroenterol Hepatol; 2013 Jul; 11(7):841-6. PubMed ID: 23353641 [TBL] [Abstract][Full Text] [Related]
45. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. Lindor KD N Engl J Med; 1997 Mar; 336(10):691-5. PubMed ID: 9041099 [TBL] [Abstract][Full Text] [Related]
47. Sclerosing cholangitis with granulocytic epithelial lesion: a benign form of sclerosing cholangiopathy. Zen Y; Grammatikopoulos T; Heneghan MA; Vergani D; Mieli-Vergani G; Portmann BC Am J Surg Pathol; 2012 Oct; 36(10):1555-61. PubMed ID: 22982898 [TBL] [Abstract][Full Text] [Related]
48. Bone disorders in cholestatic liver diseases. Isaia G; Di Stefano M; Roggia C; Ardissone P; Rosina F Forum (Genova); 1998; 8(1):28-38. PubMed ID: 9514992 [TBL] [Abstract][Full Text] [Related]
50. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group. van Hoogstraten HJ; Vleggaar FP; Boland GJ; van Steenbergen W; Griffioen P; Hop WC; van Hattum J; van Berge Henegouwen GP; Schalm SW; van Buuren HR Am J Gastroenterol; 2000 Aug; 95(8):2015-22. PubMed ID: 10950051 [TBL] [Abstract][Full Text] [Related]
51. Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series. Schramm C; Schirmacher P; Helmreich-Becker I; Gerken G; zum Büschenfelde KH; Lohse AW Ann Intern Med; 1999 Dec; 131(12):943-6. PubMed ID: 10610645 [TBL] [Abstract][Full Text] [Related]
54. Primary sclerosing cholangitis in a child. Lin WT; Lin SJ; Ni YH; Chen HL; Wang HP; Chu JS; Chang MH J Formos Med Assoc; 1999 Mar; 98(3):209-13. PubMed ID: 10365542 [TBL] [Abstract][Full Text] [Related]
56. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. Stiehl A; Walker S; Stiehl L; Rudolph G; Hofmann WJ; Theilmann L J Hepatol; 1994 Jan; 20(1):57-64. PubMed ID: 8201224 [TBL] [Abstract][Full Text] [Related]
57. Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis. Singh S; Khanna S; Pardi DS; Loftus EV; Talwalkar JA Inflamm Bowel Dis; 2013 Jul; 19(8):1631-8. PubMed ID: 23665966 [TBL] [Abstract][Full Text] [Related]
58. Pathogenesis and medical therapy of primary sclerosing cholangitis. van Milligen de Wit AW Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):940. PubMed ID: 10514135 [No Abstract] [Full Text] [Related]
59. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Beuers U; Spengler U; Kruis W; Aydemir U; Wiebecke B; Heldwein W; Weinzierl M; Pape GR; Sauerbruch T; Paumgartner G Hepatology; 1992 Sep; 16(3):707-14. PubMed ID: 1505913 [TBL] [Abstract][Full Text] [Related]